查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1993837

腦血管造影術市場：依影像技術、應用、病患年齡、適應症、最終使用者、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Cerebral Angiography Market, By Imaging Technique, By Application, By Patient Age, By Indication, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 295 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年腦血管造影術市場價值 13.5891 億美元，預計從 2026 年到 2033 年將以 6.70% 的複合年成長率成長。

腦血管造影術是一種影像診斷技術，透過向動脈系統注入造影劑並收集X光影像，使腦血管可視化，從而使臨床醫生能夠以高解析度和高精度檢測血管異常，例如動脈瘤、動靜脈畸形和血管閉塞。其應用範圍涵蓋腦血管系統的詳細評估，並常用於治療計劃和血管內治療。從公共衛生角度來看，來自各國政府和世界衛生組織的權威數據表明，腦血管疾病，尤其是中風，造成了沉重的健康負擔，也是推動先進神經血管成像技術需求的主要因素。世界衛生組織（WHO）已將中風列為全球主要的死亡和殘疾原因之一，其發病率和盛行率仍然居高不下，凸顯了精準血管成像在醫療保健系統和臨床路徑中的核心作用。

腦血管造影術市場－市場動態

全球中風和腦血管疾病負擔日益加重

中風和其他腦血管疾病發生率的上升是推動腦血管造影術需求成長的主要因素。腦血管造影術廣泛用於觀察腦血管，診斷動脈瘤、血管畸形和動脈阻塞等可能導致中風的異常情況。隨著全球中風病例數的增加，醫療系統需要更先進的影像技術來支援精準診斷和治療方案的發展。根據政府和公共衛生統計數據，中風是全球面臨的重大負擔。世界衛生組織（WHO）報告稱，全球每年新增數百萬例中風病例，數百萬人患有中風後遺症。該組織還預測，四分之一的成年人一生中會經歷中風，凸顯了神經系統疾病影像檢查日益成長的需求。由於腦血管血管造影術能夠提供腦血管的詳細影像，醫院和神經血管中心擴大利用這項技術來識別血管異常並制定介入治療方案。隨著世界各地醫療統計數據不斷報告中風及相關血管疾病的發病率，對精確的神經血管成像技術的需求日益成長，這可能會加速醫療機構採用腦血管造影術系統。

腦血管造影術市場－市場區隔分析：

全球腦血管血管造影術市場按影像技術、應用、患者年齡、適應症、最終用戶和地區進行細分。

在市場框架內，根據影像技術可分類出四個細分市場：數位減影血管攝影檢查（DSA）、磁振血管攝影檢查（MRA）、電腦斷層血管攝影檢查（CTA）和導管血管攝影檢查。數位減影血管攝影檢查（DSA）能夠提供腦血管的高解析度即時影像，因此在腦血管造影術市場中佔據重要地位，特別適用於識別動脈瘤、動靜脈畸形和血管狹窄。雖然磁振血管造影術（MRA）和電腦斷層血管血管造影術（CTA）等無創技術正日益普及，但DSA對於複雜病例和手術規劃仍然至關重要。公共衛生指南也支持其應用。美國心臟協會（AHA）報告稱，美國每年約有10萬例中風，凸顯了精準血管成像的必要性。英國國家醫療服務體系 (NHS) 也建議在介入治療過程中需要精確血管定位的病例中使用數位減影血管攝影 (DSA)。這些因素共同凸顯了 DSA 在臨床實務中持續的重要性。

根據應用領域，市場結構可分為三個部分：神經內科、神經外科和介入放射學。神經內科領域已成為腦血管血管造影術市場的關鍵細分領域。這是因為腦血管攝影廣泛用於診斷和後續觀察腦血管疾病，例如中風、動脈瘤和動靜脈畸形。腦血管造影術可為神經科提供腦血管的詳細影像，從而支持神經血管疾病的快速診斷和有效治療。早期發現異常是預防併發症的關鍵。公共衛生數據也強調了這項需求。根據美國疾病管制與預防中心 (CDC) 統計，美國每年有數百萬人發生中風，其中數十萬人為首次中風。同時，世界衛生組織 (WHO) 指出，腦血管疾病是全球數百萬人死亡的原因。這些數據凸顯了神經影像學在臨床護理和公共衛生規劃中的重要性，並強調了神經病學作為推動腦血管造影術需求的主要應用領域的重要性。

腦血管造影術市場—區域趨勢

在全球腦血管血管造影術市場中，北美和亞太地區佔據主導地位，這主要歸因於醫療基礎設施、疾病盛行率和技術應用方面的差異。北美佔據最大的市場佔有率，約為41.8%，這得益於其先進的醫療體系、神經影像技術的廣泛應用以及對腦血管疾病診斷和治療的大量投入。美國和加拿大的高卒中發病率，加上CT和MRI掃描儀的廣泛使用，維持了對精細血管成像的需求。亞太地區雖然目前的市場佔有率較小，但由於中國和印度等國家醫療基礎設施的不斷完善、人們對卒中和神經血管疾病的認知不斷提高，以及政府為改善先進診斷技術的可及性而採取的舉措，該地區正經歷快速成長。龐大的人口基數和不斷上升的卒中病例數也推動了這些因素的發展。這些趨勢凸顯了醫療體系、疾病負擔和公共部門的支持如何影響腦血管血管造影術在區域層面的應用和普及。

腦血管造影術市場—各國市場洞察

在全球範圍內，美國在腦血管造影術市場佔據著舉足輕重的地位，這主要得益於先進神經影像工具的廣泛應用以及對精細血管診斷的需求。美國面臨中風和其他腦血管疾病帶來的沉重負擔。根據美國疾病管制與預防中心（CDC）統計，美國每年有數十萬人發生中風，其中約有數十萬人是首次中風。這些病例中約87%為缺血性中風，需要精確的影像檢查才能進行有效治療。這些數據凸顯了腦血管攝影的巨大需求。腦血管攝影能夠偵測腦血管系統的異常情況，並提供腦血管造影術的詳細影像，進而輔助臨床決策。高發病率、完善的醫療基礎設施以及先進影像系統的普及，共同鞏固了美國在全球市場的主導地位。

目錄

第1章：腦血管造影術市場概覽

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：腦血管造影術的主要市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：血管造影術產業的分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：腦血管血管造影術市場：地緣政治張力加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：血管造影術市場現狀

  • 腦血管造影術市場佔有率分析，2025年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章：腦血管血管造影術市場：依影像技術分類

  • 概述
    • 細分市場佔有率分析：依診斷影像技術分類
    • 數位減影血管攝影檢查（DSA）
    • 磁振血管造影術（MRA）
    • 電腦斷層血管造影術（CTA）
    • 導管血管造影術
    • 術中血管造影術

第8章：腦血管造影術市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 神經病學
    • 神經外科
    • 介入放射學
    • 其他

第9章：血管造影術市場：依病患年齡分類

  • 概述
    • 細分市場佔有率分析：依患者年齡分類
    • 成年患者
    • 兒童患者

第10章：血管造影術市場：依適應症分類

  • 概述
    • 基於細分市場的市佔率分析：按適應症
    • 中風
    • 動脈瘤
    • 動靜脈畸形（AVM）
    • 頸動脈疾病
    • 腦腫瘤

第11章：腦血管血管造影術市場：依最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 醫院
    • 診斷影像中心
    • 神經科專科診所
    • 研究機構
    • 門診手術中心

第12章：腦血管血管造影術市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他中東和非洲國家

第13章：主要供應商分析：血管造影術產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
  • GE醫療
  • 西門子醫療內部
  • Koninklijke Philips NV
  • 島津公司
  • Canon Medical Systems Corporat
  • 三星麥迪遜
  • St. Jude Medical, Inc.
  • 日立醫療株式會社
  • Terumo Corporation
  • Medtronic plc
  • 打擊者公司
  • AngioDynamic, Inc.
  • Penumbra, Inc.
  • MicroPort Scientific Corporation
  • Cordis
  • Cook Medical LLC

第14章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV6196

Cerebral Angiography Market size was valued at US$ 1,358.91 Million in 2025, expanding at a CAGR of 6.70% from 2026 to 2033.

Cerebral angiography is a diagnostic imaging technique in which a contrast agent is introduced into the arterial system and X ray images are acquired to visualize the blood vessels of the brain, enabling clinicians to detect vascular abnormalities such as aneurysms, arteriovenous malformations, and occlusions with high resolution and precision. Its application extends to a detailed assessment of cerebral vasculature and is often integrated into treatment planning and endovascular interventions. At the public health level, authoritative government and global health data indicate that cerebrovascular diseases, particularly stroke, constitute a substantial health burden and a key driver of demand for advanced neurovascular imaging; stroke is recognized by the World Health Organization as one of the leading causes of death and disability globally, demonstrating persistent incidence and prevalence that reinforce the central role of accurate vascular imaging in health systems and clinical pathways.

Cerebral Angiography Market- Market Dynamics

Increasing Global Burden of Stroke and Cerebrovascular Diseases

The rising prevalence of stroke and other cerebrovascular conditions is a major factor supporting the demand for cerebral angiography procedures. Cerebral angiography is widely used to visualize blood vessels in the brain and diagnose abnormalities such as aneurysms, vascular malformations, and arterial blockages that can lead to stroke. As the number of stroke cases increases globally, healthcare systems require more advanced imaging procedures to support accurate diagnosis and treatment planning. Government and public health statistics indicate a significant global burden of stroke. According to the World Health Organization (WHO), millions of new stroke cases occurred worldwide, and about millions of people were living with stroke globally. The organization also reports that one in four adults is expected to experience a stroke during their lifetime, highlighting the growing need for diagnostic imaging in neurological care. Because cerebral angiography provides detailed images of cerebral blood vessels, hospitals and neurovascular centers increasingly use it for confirming vascular abnormalities and planning interventional procedures. As the incidence of stroke and related vascular disorders continues to be reported in national health statistics, the need for accurate neurovascular imaging technologies is likely to support the adoption of cerebral angiography systems in healthcare facilities.

Cerebral Angiography Market- Segmentation Analysis:

The Global Cerebral Angiography Market is segmented on the basis of Imaging Technique, Application, Patient Age, Indication, End User, and Region.

The market framework identifies four segments based on imaging technique: Digital Subtraction Angiography (DSA), Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), and Catheter Angiography. Digital Subtraction Angiography (DSA) continues to represent a key segment in the cerebral angiography market due to its ability to provide highly detailed, real-time images of brain blood vessels, making it particularly useful for identifying aneurysms, arteriovenous malformations, and vascular narrowing. While non-invasive techniques such as Magnetic Resonance Angiography (MRA) and Computed Tomography Angiography (CTA) are gaining popularity, DSA remains essential for complex cases and surgical planning. Public health guidance supports its use: the American Heart Association reports approximately lakhs of strokes in the U.S. each year, emphasizing the need for precise vascular imaging, and the UK's National Health Service recommends DSA for cases requiring accurate vascular mapping during interventions. These factors collectively underscore DSA's continued prominence in clinical practice.

The market framework identifies three segments based on application: Neurology, Neurosurgery, and Interventional Radiology. The Neurology segment emerges as a significant segment in the cerebral angiography market, as it is widely used to diagnose and monitor cerebrovascular conditions such as stroke, aneurysms, and arteriovenous malformations. Cerebral angiography provides neurologists with detailed images of brain blood vessels, supporting timely diagnosis and effective management of neurovascular disorders, with early detection of abnormalities being key to preventing complications. Public health data underscores this need: the Centre for Disease Control and Prevention (CDC) reports that people in the U.S. experience a stroke each year, including approximately lakhs of first-time cases, while the World Health Organization (WHO) notes that cerebrovascular diseases cause over millions of deaths globally. These figures highlight the importance of neurological imaging in both clinical care and public health planning, reinforcing neurology as the primary application driving demand for cerebral angiography.

Cerebral Angiography Market- Geographical Insights

In the global cerebral angiography market, North America and Asia Pacific are notable leaders due to differences in healthcare infrastructure, disease prevalence, and technology adoption. North America holds the largest share, around 41.8 %, driven by advanced healthcare systems, widespread availability of neuroimaging technologies, and significant investment in diagnostic and interventional care for cerebrovascular diseases; the high incidence of stroke in the U.S. and Canada, combined with the extensive use of CT and MRI scanners, sustains demand for detailed vascular imaging. Asia Pacific, while smaller in current share, is experiencing rapid growth due to expanding healthcare infrastructure in countries like China and India, increasing awareness of stroke and neurovascular conditions, and government initiatives to improve access to advanced diagnostics, supported by large populations and a rising number of stroke cases. These trends highlight how healthcare capacity, disease burden, and public sector support influence the adoption and expansion of cerebral angiography across regions.

Cerebral Angiography Market- Country Insights

Worldwide, the United States maintains a strong presence in the cerebral angiography market, driven by the adoption of sophisticated neuroimaging tools and the need for detailed vascular diagnosis. The country faces a considerable burden of stroke and other cerebrovascular conditions; the Centre for Disease Control and Prevention (CDC) reports that over lakhs of people in the U.S. experience a stroke each year, including approximately lakhs of first-time strokes, with about 87 % being ischemic strokes that require precise imaging for effective treatment. These figures highlight the demand for cerebral angiography, which offers detailed visualization of brain blood vessels to detect abnormalities and assist in clinical decision-making. The combination of high disease prevalence, robust healthcare infrastructure, and access to advanced imaging systems reinforces the United States leading position in the global market.

Cerebral Angiography Market- Competitive Landscape:

In the competitive landscape of the cerebral angiography market, a number of established medical imaging and device companies offer advanced angiography systems, software, and supporting technologies for detailed visualization of cerebral blood vessels and efficient clinical workflows. Leading global players such as GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems are known for their comprehensive cerebral angiography solutions and continuous improvements in imaging quality and clinical support. Other important contributors, including Shimadzu Corporation, Boston Scientific Corporation, AngioDynamics, and Medtronic, add variety to the market with specialized products designed for diverse healthcare environments. These companies sustain their market presence through ongoing research and development, wide distribution channels, and product updates that address clinical demands, particularly for diagnosing and managing neurovascular diseases like stroke, which remains a priority for public health authorities and national healthcare planning.

Recent Developments:

In December 2025, Stratasys announced full commercial availability of its RadioMatrix radiopaque 3D printing material across the U.S., enabling healthcare providers and researchers to create patient-specific models with tunable X-ray visibility for imaging and training. This development is expected to enhance medical education, improve procedural planning, and support more accurate simulations, ultimately contributing to better patient outcomes and advancing innovation in medical imaging technologies.

In February 2025, the FDA granted 510(k) clearance to RapidAI's Lumina 3D software, which delivers AI-powered 3D CTA reconstructions of head and neck scans within minutes, improving visualization and accelerating neuroradiology workflow. This advancement is set to streamline diagnostic processes, enhance clinical decision-making, and support faster, more precise patient care in neuroradiology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CEREBRAL ANGIOGRAPHY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GE Healthcare
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • Shimadzu Corp.
  • Canon Medical Systems Corporation
  • Samsung Medison
  • St. Jude Medical, Inc.
  • Hitachi Medical Corporation
  • TERUMO Corporation
  • Medtronic plc
  • Stryker Corporation
  • AngioDynamic, Inc.
  • Penumbra, Inc.
  • MicroPort Scientific Corporation
  • Cordis
  • Cook Medical LLC

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY IMAGING TECHNIQUE- MARKET ANALYSIS, 2020 - 2033

  • Digital Subtraction Angiography (DSA)
  • Magnetic Resonance Angiography (MRA)
  • Computed Tomography Angiography (CTA)
  • Catheter Angiography
  • Intraoperative Angiography

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Neurology
  • Neurosurgery
  • Interventional Radiology
  • Others

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY PATIENT AGE- MARKET ANALYSIS, 2020 - 2033

  • Adult Patients
  • Pediatric Patients

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY INDICATION- MARKET ANALYSIS, 2020 - 2033

  • Stroke
  • Aneurysm
  • Arteriovenous Malformation (AVM)
  • Carotid Artery Disease
  • Brain Tumors

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Hospitals
  • Diagnostic Imaging Centers
  • Specialty Neurology Clinics
  • Research Institution
  • Ambulatory Surgical Centers

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cerebral Angiography Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cerebral Angiography Market Snippet by Imaging Technique
    • 2.1.2. Cerebral Angiography Market Snippet by Application
    • 2.1.3. Cerebral Angiography Market Snippet by Patient Age
    • 2.1.4. Cerebral Angiography Market Snippet by Indication
    • 2.1.5. Cerebral Angiography Market Snippet by End User
    • 2.1.6. Cerebral Angiography Market Snippet by Country
    • 2.1.7. Cerebral Angiography Market Snippet by Region
  • 2.2. Competitive Insights

3. Cerebral Angiography Key Market Trends

  • 3.1. Cerebral Angiography Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cerebral Angiography Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cerebral Angiography Market Opportunities
  • 3.4. Cerebral Angiography Market Future Trends

4. Cerebral Angiography Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cerebral Angiography Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cerebral Angiography Market Landscape

  • 6.1. Cerebral Angiography Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cerebral Angiography Market - By Imaging Technique

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Imaging Technique, 2025 & 2033 (%)
    • 7.1.2. Digital Subtraction Angiography (DSA)
    • 7.1.3. Magnetic Resonance Angiography (MRA)
    • 7.1.4. Computed Tomography Angiography (CTA)
    • 7.1.5. Catheter Angiography
    • 7.1.6. Intraoperative Angiography

8. Cerebral Angiography Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Neurology
    • 8.1.3. Neurosurgery
    • 8.1.4. Interventional Radiology
    • 8.1.5. Others

9. Cerebral Angiography Market - By Patient Age

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Patient Age, 2025 & 2033 (%)
    • 9.1.2. Adult Patients
    • 9.1.3. Pediatric Patients

10. Cerebral Angiography Market - By Indication

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Indication, 2025 & 2033 (%)
    • 10.1.2. Stroke
    • 10.1.3. Aneurysm
    • 10.1.4. Arteriovenous Malformation (AVM)
    • 10.1.5. Carotid Artery Disease
    • 10.1.6. Brain Tumors

11. Cerebral Angiography Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Diagnostic Imaging Centers
    • 11.1.4. Specialty Neurology Clinics
    • 11.1.5. Research Institution
    • 11.1.6. Ambulatory Surgical Centers

12. Cerebral Angiography Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Cerebral Angiography Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Cerebral Angiography Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Cerebral Angiography Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Cerebral Angiography Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Cerebral Angiography Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Cerebral Angiography Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
  • 13.3. GE Healthcare
  • 13.4. Siemens Healthineers
  • 13.5. Koninklijke Philips N.V.
  • 13.6. Shimadzu Corp.
  • 13.7. Canon Medical Systems Corporation
  • 13.8. Samsung Medison
  • 13.9. St. Jude Medical, Inc.
  • 13.10. Hitachi Medical Corporation
  • 13.11. TERUMO Corporation
  • 13.12. Medtronic plc
  • 13.13. Stryker Corporation
  • 13.14. AngioDynamic, Inc.
  • 13.15. Penumbra, Inc.
  • 13.16. MicroPort Scientific Corporation
  • 13.17. Cordis
  • 13.18. Cook Medical LLC

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us